Arsenic Trioxide Injection, Solution
FDA Label NDC 49315-005

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Arsenic Trioxide (NDC 49315-005). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

PRINCIPAL DISPLAY PANEL - Vial Label

NDC 49315-005-01

Arsenic Trioxide Injection

10 mg/10 mL

(1 mg/mL)

For Intravenous Use Only

Cytotoxic Agent

10 mL Single-Dose Vial

Rx only

Zydus Pharmaceuticals

Vial Label (98485817 7110 4b6d 9302 D2f74e264bfa 02)

Vial Label (98485817 7110 4b6d 9302 D2f74e264bfa 02)

PRINCIPAL DISPLAY PANEL - Carton Label

NDC 49315-005-10

Arsenic Trioxide Injection

10 mg/10 mL

(1 mg/mL)

For Intravenous Use Only

10 X 10 mL Single-Dose Vials

Rx only

Zydus Pharmaceuticals

Carton Label (98485817 7110 4b6d 9302 D2f74e264bfa 03)

Carton Label (98485817 7110 4b6d 9302 D2f74e264bfa 03)

* Please review the disclaimer below.